INMB
INmune Bio Inc
2.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3,700.8% | +3,977.3% | -5.7% | +40.9% | +66.1% | +145.8% | -18.2% | -30.3% | -30.6% | -18.2% | |
| – | +3,700.8% | +320.6% | -55.3% | +814.2% | +208.9% | +244.4% | -21.7% | -38.2% | -43.3% | +31.9% | |
| – | +1,092.2% | +867.6% | -86.4% | +3,656.9% | +214.0% | +240.6% | -30.3% | -31.3% | -41.6% | +18.3% | |
| – | +1,092.2% | +867.6% | -86.4% | +3,656.9% | +214.0% | +240.6% | -30.3% | -31.3% | -41.6% | +18.3% | |
| – | – | +25.8% | +97.7% | -0.3% | +178.8% | +205.9% | +53.7% | -71.1% | -42.3% | +222.3% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -18.4% | +364.7% | -30.2% | – | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | |
| – | +1,853.9% | -48.5% | +166.0% | +4.5% | +121.0% | +936.8% | +10.0% | -13.0% | -60.4% | +18.2% | |
| – | +1,853.9% | -48.5% | +166.0% | -15.0% | +153.6% | +145.4% | +150.5% | +69.1% | -60.9% | +16.5% | |
| – | – | – | – | – | +310.2% | +111.8% | +6,965.3% | +97.4% | -98.6% | +345.0% | |
| – | +29,341.3% | -38.2% | +305.6% | -27.3% | +277.6% | +150.5% | +36.9% | +51.8% | -16.9% | +18.3% | |
| – | – | – | – | – | – | – | -32.9% | – | – | – | |
| – | – | – | -8.6% | +42.7% | +64.1% | +107.0% | -25.1% | -36.5% | -15.8% | -26.7% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.2% | +119.6% | +0.0% | -8.4% | +16.7% | +34.6% | +11.1% | +0.3% | +10.9% | +33.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.